Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modalis Therapeutics Corporation ( (JP:4883) ) has shared an announcement.
Modalis Therapeutics Corporation reported its consolidated financial results for the fiscal year ended December 31, 2024, showing a significant reduction in losses compared to the previous year. Despite the financial improvements, the company has not issued any earnings forecasts for 2025 due to uncertainties in the market.
More about Modalis Therapeutics Corporation
Modalis Therapeutics Corporation is a company listed on the Tokyo Stock Exchange that operates in the therapeutic industry. It focuses on developing innovative solutions in the biotechnology sector.
YTD Price Performance: -2.94%
Average Trading Volume: 8,379,093
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen7.2B
For an in-depth examination of 4883 stock, go to TipRanks’ Stock Analysis page.